IDEXX Laboratories EPS Forecast Shows Positive Trends Ahead

IDEXX Laboratories is set to report Q4 earnings. Analysts expect EPS to rise to $2.40, indicating a slight increase from last year. The forecast for fiscal 2024 EPS is also optimistic, projecting $10.44, reflecting steady growth.

Date: 09-01-2025

AI Rating: 6

Profit Margins and Earnings Per Share (EPS): Analysts project that IDEXX will report a profit of $2.40 per share for Q4, which is a 3.5% increase from the previous year's $2.32. This consistent growth in EPS shows that the company is maintaining profitability despite challenges.

For fiscal year 2024, expectations for EPS rise to $10.44, up 3.8% from $10.06 in the previous year, and to $12.01 in fiscal 2025, indicating strong growth potential.

Despite a decline of 20.5% in shares over the last year, significantly lagging the S&P 500 Index's 24.2% rise, the general analyst sentiment remains moderately optimistic. Five analysts have upgraded their ratings for the stock to "Strong Buy," revealing some Recovery in sentiment.

Investors' Outlook: The average price target for IDXX shares stands at $494.60, showing a potential upside of 14.4% from current levels. Overall, while the short-term outlook does present challenges due to recent performance, the EPS growth indicates potential for recovery, making it a stock to watch going forward.

Stocks: IDXX